Industry | 2017.06.19
Global biotech industry continues to attract financing despite reimbursement, regulatory and political challenges
NEW YORK, June 19, 2017 /PRNewswire/ -- Global biotech companies continued to invest in new treatments despite a pull back from capital markets in the US and the EU, lower valuations and increased pressure from payers, according to the 31st annual EY report Beyond borders:...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]ical-challenges-300475545.html
